July 2015

Jul

Biofortuna launches its new approach to custom IVD manufacture and development services

Diagnostics company Biofortuna will mark the 2015 AACC Annual Meeting and Clinical Lab Expo in Atlanta, USA, with the launch of a broader portfolio of custom manufacturing and development services for the IVD market. World-renowned for its lyophilisation services and molecular diagnostic products, Biofortuna has developed a new internal infrastructure, creating distinct products and services divisions and giving the company

Biofortuna

Biofortuna is a specialist contract development and manufacturing organisation providing Genomic services, custom development and manufacturing support.

Operating from state-of-the art, humidity-controlled premises, and benefiting from ISO 17025 accreditation, ISO 13485 certification and FDA registration, we have a proven track record in the development and large-scale manufacture of PCR and LAMP molecular assays and Immunoassays.